Skip to main content
. 2012 Dec 4;7(12):e50229. doi: 10.1371/journal.pone.0050229

Figure 4. Effects of SFRP2 shRNA on the protein expression of SFRP2 and Slug in HSFBs.

Figure 4

The SFRP2 protein level was significantly increased and decreased in the non- transfected HSFBs (Inline graphic = 1.06, s = 0.15) and the SFRP2 shRNA group (Inline graphic = 0.14, s = 0.02), respectively, compared with the normal skin fibroblasts (Inline graphic = 0.36, s = 0.05). And the protein expression of SFRP2 in HSFBs transfected with control shRNA (Inline graphic = 0.90, s = 0.06) was not significantly decreased than that in non-transfected HSFBs. After the treatments of the shRNAs, the SFRP2 protein level was significantly lower than that in the HSFBs and the HSFBs transfected with control shRNA (A and B). Similar to the effects on the expression of SFRP2, Slug expression was significantly higher in the non- transfected HSFBs and HSFBs transfected with control shRNA than that in normal skin fibroblasts both in mRNA (Inline graphic = 0.70, s = 0.08; Inline graphic = 0.63, s = 0.10; Inline graphic = 0.37, s = 0.05, respectively) and protein levels (Inline graphic = 0.90, s = 0.04; Inline graphic = 0.84, s = 0.11; Inline graphic = 0.43, s = 0.04, respectively). Moreover, both the Slug mRNA and protein levels were significantly decreased in HSFBs transfected with SFRP2 shRNA (Inline graphic = 0.20, s = 0.06; Inline graphic = 0.25, s = 0.05, respectively) compared with the non- transfected HSFBs and HSFBs transfected with control shRNA (B- F). *: P<0.01 versus Normal skin fibroblast; : P<0.01 versus Control shRNA; : P<0.01 versus HSFBs.